Guidance

ARSAC notes for guidance: good clinical practice in nuclear medicine

Guidance on licencing and best use of radiopharmaceuticals and sealed radioactive sources in diagnosis, treatment or research.

From:
Administration of Radioactive Substances Advisory Committee
Published
17 April 2014
Last updated
1625 FebruaryMarch 20232024 — See all updates

Documents

Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources

Ref: UKHSA publications gateway number GOV-14149 GOV-15859

PDF, 717868 KB, 7785 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email arsac@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).

The FebruaryMarch 20232024 version contains notable updates from the previous version, as detailed on page one.

Published 17 April 2014
Last updated 1625 FebruaryMarch 20232024 + show all updates

  1. Added March 2024 update.

  2. Added February 2023 update.

  3. Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources' (see page 1 for the latest changes).

  4. Edited ‘Section 3: Applying for a practitioner licence’.

  5. Added February update.

  6. Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.

  7. Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.

  8. Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.

  9. Updated notes to clarify the licencing process.

  10. Replaced 'notes for guidance' document and updated detail text.

  11. Uploaded the 2017 edition of guidance.

  12. January 2016 update to guidance.